Coria LJJ, Rosales UE, Matías JNA, Juárez EM

Language: Spanish
References: 34
Page: 185-192
PDF size: 86.92 Kb.

ABSTRACT

Viral infections in pediatric patients result in a rise morbility and mortality (the last, mainly in the immunocompromised children), beside to high cost in medical care. All infants and children (who are previously healthy or are immunocompromised) may have viral illnesses severe enough to require care in the pediatric intensive care unit. Children immunocompromised are most susceptible to develop more severe local or/and disseminated viral disease. This review describe the use of antiviral agents in the different diseases caused mainly for the herpesvirus family, and certain viral respiratory infections, which are been common cause of consultation in the pediatric clinical practice. The purpose of this issue is than the pediatrician consult have an tool when he need select something treatment.

REFERENCES

1. Center for Evidence Bases Medicine, Universidad de Oxford, http//cebm.jr2.ox.ac.uk/ebmisisnt.html, Mayo 2000.

2. Harrison ChJ. Antivirales other than for HIV therapy. Advan Pediatr 2000; 47: 335-94.

3. Whitley RJ. Approaches to therapy of viral infections. Adv Pediatr 1987; 34: 89-110.

4. Muñoz FM. Critical care in infectious diseases, part II: Antiviral agents in the critically ill child. Semin Pediatr Infect Dis 2000; 11: 35-42.

5. Straus ES. Introduction to herpesviridae. In: Mandell LG, Bennett EJ, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Churchill Livingstone 2000: 1557-64.

6. Whitley RJ, Hutto C. Neonatal herpes, simplex virus infections. Pediatric Rev 1985: 7119-126.

7. Corey L. Herpes simplex virus. In: Mandell LG, Bennett EJ, Dolin R. (eds). Principles and Practice of Infectious Diseases. Churchill Livingstone, 5th ed. 2000: 1564-1580.

8. Coria LJJ, Juárez EM, Velazco AVH. Meningoencefalitis viral. Enfoque clínico. Rev Mex Pediatr 2001; 68: 252-9.

9. Crane N, Lerner A. Herpetic withhold. A manifestation of primary infection with herpes simplex virus type 1 and 2. J Infect Dis 1978; 137: 855-6.

10. Grose C. Varicella-zoster virus: Pathogenesis of primary infection. In: Arvin AM, Gershon AA, eds: Varicella-zoster virus: Virology and Clinical Practice. Cambridge, MA, Cambridge Press, 2000: 105-113.

11. Arvin AM. Antiviral therapy for varicella and herpes zoster. Semin Pediatr Infect Dis 2002; 13: 12-21.

12. Feldman S, Lott L. Varicella in children with cancer: Impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80: 465-572.

13. Whitley RJ. Varicella-zoster virus infections. In: Galasso GJ, Whitley RJ, Merigan TC eds. Antiviral Agents and Viral Diseases of Man. New York, NY. Raven, 1990: 235-63.

14. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Inf Dis J 1992; 11: 441-5.

15. American Academy of Pediatrics. Committee on Infectious Diseases. Varicella-zoster infections, Red Book 2000: 624-638.

16. Caltenco RS, Field JC. Varicela. En: Gómez DB, Coria JJL (eds). Infectología Práctica en el Paciente Pediátrico. Ed. Corinter, México. 1ª ed. 2003: 188-191.

17. Gershon AA. Varicela-zoster virus: Prospects for control. Advanc Pediatr Infect Dis 1995; 10: 93-124.

18. Srabstein JC, Morris N, Larke B et al. Is there a congenital varicella syndrome? J Pediatr 1974; 84: 239-243.

19. Da Silva O, Ilammerbert O, Chance GW. Fetal varicella syndrome. Pediatr Infect Dis J 1990; 9: 854-855.

20. Crumpacker SC. Cytomegalovirs. In: Mandell LG, Bennett EJ, Dolin R. (eds.). Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia. Fifty Ed. 2000: 1586-1598.

21. Canpolat C, Culbert S, Gardner M et al. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 589-593.

22. Couchoud C, Cucherat M, Haugh M et al. Cytomegalovirs prophylaxis with antiviral agents in solid organ transplantation: A meta analysis. Transplantation 1998; 65: 641-647.

23. Nigro G, Krzysztofiak A, Bartmann U et al. Ganciclovir for cytomegalovirus associated liver disease in immunocompetent or immunocompromised children. Arch Virol 1997; 142: 573-580.

24. Schooley TR. Epstein-Barr virus (Infectious mononucleosis). In: Mandell LG, Bennett FJ, Dolin R. (eds). Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia. Fifty Ed. 2000: 1599-1613.

25. Kaiser L, Couch RB, Galasso GJ et al. First International Symposium on Influenza and Other Respiratory Viruses: Summary and overview. Kapalua, Maui, HI, December 4-6, 1998. Antiviral Res 1999; 42: 149-176.

26. Breese CH. Respiratory syncytial virus and parainfluenza virus. NEJM 2001; 344: 25: 1917-1828.

27. Johnston SL, Pattermore PK, Sanderson G et al. Community study of role of viral infection in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1229.

28. González SN, Saltigeral SP. Antivirales. En: González SN, Saltigeral eds. Antimicrobianos, Antivirales, Antiparasitarios, Antimicóticos e Inmunomoduladores. 5ª ed. México: McGraw-Hill 2001: 210-229.

29. Kimberlin WD. Acyclovir derivates and other new antiviral agents. Semin Pediatr Infect Dis 2001; 12: 224:34.

30. Wood JA. Drug therapy. Acyclovir: A decade later. NEJ 1992; 327(11): 782-7.

31. Prober ChG. Antiviral therapy for influenza virus infections. Semin Pediatr Infec Dis 2002; 13: 31-9.

32. Lin TZ, Huang YCh, Ning HCh, Hsueh Ch. Oral acyclovir prophylaxis of varicella after intimate contact. Pediatr Infect Dis J 1997; 16(12): 1162-1165.

33. Kumagai T, Kamada M, Igarashi Ch, Yuri K, Furukawa H, Chiba S et al. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure. J Infect Dis 1999; 180: 834-7.

34. White ChB, Hawley WZ, Harford DJ. The pediatric resident susceptible to varicella: Providing immunity through postexposure prophylaxis with oral acyclovir. Pediatr Infect Dis J 1994; 13: 743-4.